Havana, June 25 (Prensa Latina) A genetic engineering institute in Cuba has registered an antibody that can be used in the production of an anti-hepatitis B vaccine.
This breakthrough in vaccine production was achieved by the Centre for Genetic Engineering and Biotechnology (CIGB) here. CIGB Deputy Director General Carlos Borroto described it as a world scientific breakthrough at a press conference here.
Borroto said that the antibody, called CB-Hep.1, made of plants would contribute greatly to the increased production of the anti-hepatitis B vaccine. He added that it would also lower the cost.
According to him, this breakthrough would also open doors to obtain other effective antibodies to fight illnesses, including cancer.
© 2006 Prensa Latina |